Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
What Does Index Level Tell You About The Market explains how the index reflects market conditions and helps you interpret momentum for decisions.
28,521 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
PayPal faces a tough stretch in the public eye, yet cash flow and a disciplined capital plan hint at upside. Here’s w...
The S&P 500 has slipped this year, yet three tech-focused ETFs powering AI names have kept a higher trajectory over t...
The CFTC unveiled an Innovation Task Force to steer policy on crypto, AI, and prediction markets. Regulators aim for ...
Palantir delivered an 85% year-over-year revenue surge in Q1 2026 and lifted full-year targets, but the shares are do...
Trump heads Beijing high-stakes summit as markets watch for any change in US-China policy on crypto, potentially resh...
Markets moved to risk-off trading after Xi warned of a possible clash with the United States over Taiwan, hours befor...
The SEC is poised to approve an innovation exemption to let tokenized stocks trade on onchain platforms, accelerating...
Title insurance premium volume surged nearly 14% in 2025, driven by stronger mortgage activity and ongoing demand for...
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
Three mid-cap SaaS stocks are under renewed activist scrutiny as AI-fit strategies collide with balance-sheet pressur...
Bitcoin dipped below the $60,000 level on Friday, igniting a heavy selloff in the WGMI miners ETF as top miners tumbl...